A Member of the Cancer Information Network
Cancer Information by State:
  arrow Patient Home   arrow Professional Home   arrow Newsletters   arrow Feedback Survey  
Search:
Medline
CancerConsultants.com
Both
Main Menu
Quick Links
Information by Disease
Cancer News
Conference Coverage
Oncology Stocks
AZN$44.13-0.28 (-0.63%)
NVS$54.5112-0.1288 (-0.24%)
SNY$38.13-0.05 (-0.13%)
GSK$37.592-0.128 (-0.34%)
click here
Stem Cell Transplant Information Center
Latest Stem Cell Transplant News
Single-dose Neulasta® Equivalent to Multiple Doses of Neupogen® Following Stem Cell Transplantation (1/18/2010)

Specific Receptors on Immune Cells May Predict Risk of Aspergillosis Following Allogeneic Stem Cell Transplantation (10/30/2008)

Will Intra-osseous Injection of Umbilical Cord Blood Reduce Graft Failures? (8/15/2008)

Statins May Reduce Acute Graft-versus-host Disease (6/17/2008)

No Survival Advantage for High-dose Chemotherapy with Autologous Stem Cell Support for Localized Breast Cancer (12/18/2007)

More Stem Cell Transplant News »

More Stem Cell Transplant News »
Coming Soon
Submit an Editorial
CME
Conference Coverage

30th Annual Meeting of the European Group for Blood and Marrow Transplantation (EBMT)
March 28-31, 2004 -- Barcelona, Spain

45th Annual Meeting of the American Society of Hematology
December 6-9, 2003 -- San Diego, CA

29th Annual Meeting of the European Group for Blood and Marrow Transplantation (EBMT)
July 20-23, 2003 -- Istanbul, Turkey

44th Annual Meeting of the American Society of Hematology
December 6-10, 2002 -- Philadelphia, PA

7th Congress of the European Hematology Association
June 6, 2002 -- Florence, Italy

28th Annual Meeting of the European Group for Blood and Marrow Transplantation
March 24-27, 2002 -- Montreux, Switzerland

43rd Annual Meeting of The American Society of Hematology
December 7 - 11, 2001 -- Orlando, Florida
Current Topics in Oncology

Reduced Intensity Stem Cell Transplants To Treat Malignant Disease - A Review
Author: John  Barrett MD, FRCP, FRC Path., Chief, Stem Cell Allotransplanation Unit, Hematology Branch, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD, USA

High-Dose Chemotherapy for Breast Cancer: The French Pegase Experience

 

1 Donor Lymphocyte Infusions to Treat Hematologic Malignancies in Relapse After Allogeneic Blood or Marrow Transplantation (5/13/2004)

1 Abstract and Introduction (5/13/2004)

1 Abstract and Introduction (5/13/2004)
Stem Cell Transplant Drug Pipeline
What's in the pipeline for Stem Cell Transplant.
Learn More »
Newsletters
Register in our member center today to receive a monthly newsletter with clinical news, conference coverage, and current topic updates.
Learn More »
Additional Resources
Information by Cancer Type



© 1998-2010 CancerConsultants.com  All Rights Reserved.